Thesis

Street consensus, scenarios, merits, risks, and invalidation triggers

AI-assisted
Thesis Summary

Microchip entered fiscal 2027 with a strengthening cyclical recovery: Q1 net sales increased 38.0% year over year and 13.2% sequentially, inventory days declined, bookings remained strong and operating leverage improved. The principal debate is whether this recovery can persist sufficiently to offset semiconductor cyclicality, limited turns-order visibility, substantial debt and geopolitical, trade and foundry exposure.

Sign in / Sign up to read more
This section is the 12-month view: analyst targets and the probability-weighted scenarios built from them. The intrinsic value at the top of this page answers a different question: what the business is worth today.
Street view · analyst 12-month targets24 analysts · as of 18 Aug 2026
Low · most bearish analyst$80.00
Mean target$109.21
High · most bullish analyst$135.00
Street targets sit above today's price; our intrinsic value sits below it. Different horizons, different questions.
Our research · scenarios, merits, risks, and invalidation triggersResearch as of 18 Sep 2026
Scenarios · 12-month scenario targetsAnchored at research date
Bear CaseDownside scenario
$80.0023%

Turns orders weaken, customers resume delaying purchases, inventory days rise and revenue or gross margin falls below guidance. Trade restrictions, geopolitical disruption, foundry constraints or refinancing pressure could amplify the operational downturn.

Base CaseCentral scenario
$109.2157%
Matches the consensus mean

Microchip broadly delivers its Q2 FY2027 guidance while inventory normalization and operating leverage continue at a moderating pace. Embedded-control demand recovers, but cyclicality, external-foundry dependence and leverage constrain conviction.

Bull CaseUpside scenario
$135.0020%

Demand and distributor sell-through continue improving, Q2 results reach or exceed guidance, factory utilization drives further margin expansion, and PCIe Gen6 design wins convert into meaningful data-center revenue. Sustained cash generation and debt reduction improve financial flexibility.

Scenarios are anchored to street consensus at the research date, with our probabilities and rationale.

Key Investment Merits
  • Q1 FY2027 net sales rose 38.0% year over year and 13.2% sequentially, while management reported strong bookings and a book-to-bill ratio well above one.
  • GAAP gross margin reached 63.2%, inventory days declined to 175 from 185 and quarterly free cash flow was $497.6 million, demonstrating substantial operating leverage.
  • PCIe Gen6 connectivity design-win programs doubled sequentially from six to twelve, providing evidence of increasing data-center and connectivity traction.
Sign in / Sign up to read more
Key Investment Risks
  • A significant portion of quarterly demand depends on turns orders, limiting shipment visibility and increasing exposure to order cancellations or push-outs.
  • Principal indebtedness was $5.40 billion at June 30, 2026, creating refinancing, interest-cost and capital-allocation constraints despite recent deleveraging.
  • Microchip remains exposed to semiconductor cyclicality, trade restrictions, geopolitical instability and third-party foundries; 67% of Q1 FY2027 net sales came from externally fabricated products.
Sign in / Sign up to read more

All scenarios are estimates and subject to change. Past performance is not indicative of future results.

Quality Pillars Members

This section is available to registered members. Create a free account or sign in to unlock the full breakdown.

Sign in / Sign up

Explore this dossier

AI-assisted, source-linked narrative; figures from company filings (SEC EDGAR) and market data. Dates shown per section. Not investment advice. Terms of Use.